Pacira BioSciences (PCRX) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free PCRX Stock Alerts $25.50 -0.40 (-1.54%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineabrdn plc Buys 56,081 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)marketbeat.com - April 25 at 6:15 AMPacira BioSciences (NASDAQ:PCRX) Hits New 12-Month Low at $25.74marketbeat.com - April 22 at 2:53 PMPacira BioSciences, Inc. (NASDAQ:PCRX) Receives Average Rating of "Buy" from Analystsamericanbankingnews.com - April 19 at 4:30 AMOversold Conditions For Pacira BioSciences (PCRX)nasdaq.com - April 17 at 8:04 AMPacira BioSciences (NASDAQ:PCRX) Shares Up 2.7%marketbeat.com - April 16 at 2:02 PMPacira BioSciences (NASDAQ:PCRX) Sets New 52-Week Low at $25.89marketbeat.com - April 15 at 2:48 PMPacira BioSciences (NASDAQ:PCRX) stock falls 4.1% in past week as three-year earnings and shareholder returns continue downward trendfinance.yahoo.com - April 11 at 9:46 AMBaillie Gifford & Co. Sells 573,810 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)marketbeat.com - April 11 at 7:23 AMUnderstanding Key Factors Behind Pacira Pharmaceuticals’ Analyst Ratingmarkets.businessinsider.com - April 9 at 2:43 PMPacira BioSciences (NASDAQ:PCRX) Given "Buy" Rating at Needham & Company LLCmarketbeat.com - April 9 at 8:30 AMCommit To Purchase Pacira BioSciences At $15, Earn 12.5% Annualized Using Optionsnasdaq.com - April 6 at 9:01 AMPacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conferenceglobenewswire.com - April 2 at 8:00 AMPacira BioSciences, Inc. (NASDAQ:PCRX) Shares Acquired by Assenagon Asset Management S.A.marketbeat.com - March 30 at 4:51 AMGradient Investments LLC Increases Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)marketbeat.com - March 29 at 3:45 PMTributary Capital Management LLC Raises Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)marketbeat.com - March 26 at 9:48 AMWellington Management Group LLP Lowers Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)marketbeat.com - March 25 at 4:09 AMDeutsche Bank AG Has $5.60 Million Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)marketbeat.com - March 22 at 4:16 AMGary W. Pace Sells 1,066 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) Stockinsidertrades.com - March 18 at 6:46 AMPCRX Apr 2024 22.500 putfinance.yahoo.com - March 16 at 8:44 AMPacira's PCRX-201 Gets FDA RMAT Designation in Knee Osteoarthritismarketwatch.com - March 13 at 8:55 PMPacira BioSciences Receives RMAT Designation For Gene Therapy Product Candidate In Osteoarthritismarkets.businessinsider.com - March 13 at 10:37 AMPacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Kneeglobenewswire.com - March 13 at 7:00 AMPacira BioSciences, Inc. (NASDAQ:PCRX) Director Sells $2,754,000.00 in Stockinsidertrades.com - March 11 at 5:35 AMSchroder Investment Management Group Cuts Stake in Pacira BioSciences, Inc. (NASDAQ:PCRX)marketbeat.com - March 10 at 7:23 AMDirector Gary Pace Sells 119,323 Shares of Pacira BioSciences Inc (PCRX)finance.yahoo.com - March 9 at 7:05 AMInsider Selling: Pacira BioSciences, Inc. (NASDAQ:PCRX) Director Sells 1,066 Shares of Stockmarketbeat.com - March 8 at 7:44 PMJPMorgan Chase & Co. Reiterates Overweight Rating for Pacira BioSciences (NASDAQ:PCRX)marketbeat.com - March 7 at 8:21 AMHC Wainwright Comments on Pacira BioSciences, Inc.'s FY2025 Earnings (NASDAQ:PCRX)marketbeat.com - March 7 at 7:53 AMPacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conferenceglobenewswire.com - March 6 at 8:00 AMQ1 2024 EPS Estimates for Pacira BioSciences, Inc. (NASDAQ:PCRX) Reduced by HC Wainwrightmarketbeat.com - March 6 at 7:31 AMGlenmede Trust Co. NA Has $10.65 Million Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)marketbeat.com - March 5 at 10:56 AMBuy Rating for Pacira Pharmaceuticals Amid Strong Growth Prospects and Robust IP Protectionmarkets.businessinsider.com - March 4 at 2:19 PMPacira BioSciences (NASDAQ:PCRX) Earns "Buy" Rating from HC Wainwrightmarketbeat.com - March 4 at 8:25 AMBuy Rating Affirmed for Pacira Pharmaceuticals Amid Strategic Growth Initiatives and Management Restructuringmarkets.businessinsider.com - March 3 at 3:48 PMNavigating 4 Analyst Ratings For Pacira BioSciencesmarkets.businessinsider.com - March 1 at 11:50 AMPacira BioSciences Full Year 2023 Earnings: EPS Beats Expectationsfinance.yahoo.com - March 1 at 11:50 AMPacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 1 at 11:50 AMPacira BioSciences (NASDAQ:PCRX) Price Target Cut to $45.00 by Analysts at Royal Bank of Canadamarketbeat.com - March 1 at 11:21 AMStrong Buy Rating for Pacira Pharmaceuticals Amid Favorable NOPAIN Act Implications and Strategic Growth Initiativesmarkets.businessinsider.com - March 1 at 6:49 AMQ4 2023 Pacira Biosciences Inc Earnings Callfinance.yahoo.com - March 1 at 6:49 AMPacira BioSciences GAAP EPS of $0.54 beats by $0.15, revenue of $181.2M beats by $0.34Mmsn.com - February 29 at 12:44 PMPacira BioSciences Inc (PCRX) Reports Record Revenues and Robust Earnings for Full-Year 2023finance.yahoo.com - February 29 at 12:44 PMPacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Resultsglobenewswire.com - February 29 at 8:00 AMPreview: Pacira BioSciences's Earningsbenzinga.com - February 28 at 4:29 PMPacira BioSciences Q4 2023 Earnings Previewmsn.com - February 28 at 4:29 PMFederated Hermes Inc. Cuts Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX)marketbeat.com - February 27 at 6:45 AMEagle Asset Management Inc. Acquires 62,597 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)marketbeat.com - February 26 at 7:57 AMPacira BioSciences (PCRX) to Release Earnings on Thursdaymarketbeat.com - February 23 at 9:50 AMPacira BioSciences, Inc. to Post Q3 2024 Earnings of $0.59 Per Share, Zacks Research Forecasts (NASDAQ:PCRX)marketbeat.com - February 23 at 7:33 AMDeutsche Bank AG Decreases Holdings in Pacira BioSciences, Inc. (NASDAQ:PCRX)marketbeat.com - February 23 at 5:15 AM Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). PCRX Media Mentions By Week PCRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCRX News Sentiment▼0.700.39▲Average Medical News Sentiment PCRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCRX Articles This Week▼33▲PCRX Articles Average Week Get Pacira BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PCRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Supernus Pharmaceuticals News Today ALX Oncology News Today Agios Pharmaceuticals News Today ADC Therapeutics News Today Atea Pharmaceuticals News Today Nektar Therapeutics News Today Seres Therapeutics News Today Corcept Therapeutics News Today Alkermes News Today Perrigo News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCRX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & CompanyThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
